References
- 1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359-86. DOI: 10.1002/ijc.2921010.1002/ijc.2921025220842
- 2. Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012: 27:409-19. DOI: 10.1111/j.2041-1014.2012.00663.x10.1111/j.2041-1014.2012.00663.x365331723134607
- 3. Atanasova KR, Yilmaz O. Looking in the Porphyromonas gingivalis cabinet of curiosities: the microbium, the host and cancer association. Mol Oral Microbiol. 2014: 29:55-66. DOI: 10.1111/omi.1204710.1111/omi.12047394914524506890
- 4. Whitmore SE, Lamont RJ. Oral bacteria and cancer. PLoS Pathog. 2014: 10:e1003933. DOI: 10.1371/journal.ppat.100393310.1371/journal.ppat.1003933396811824676390
- 5. Hooper SJ, Wilson MJ, Crean SJ. Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck. 2009: 31:1228-39. DOI: 10.1002/hed.2114010.1002/hed.2114019475550
- 6. Ahn J, Segers S, Hayes RB. Periodontal Disease, Porphyromonas Gingivalis (P. gingivalis) Serum Antibody Levels and Orodigestive Cancer Mortality. Carcinogen-esis. 2012: 33:1055-8. DOI: 10.1093/carcin/bgs11210.1093/carcin/bgs112333451422367402
- 7. Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, Reid ME, Loree TR et al. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2009: 18:2406-12. DOI: 10.1158/1055-9965.EPI-09-033410.1158/1055-9965.EPI-09-033419745222
- 8. Ahn J, Chen CY, Hayes RB. Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Cont. 2012: 23:399-404. DOI: 10.1007/s10552-011-9892-710.1007/s10552-011-9892-7376714022271008
- 9. Han YW, Houcken W, Loos BG, Schenkein HA, Tezal M. Periodontal disease, atherosclerosis, adverse pregnancy outcomes, and head-and-neck cancer. Adv Dent Res. 2014: 26:47-55. DOI: 10.1177/002203451452833410.1177/002203451452833424736704
- 10. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B, Bartek J. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res. 1995: 55:949-56.
- 11. Hohberger L, Wuertz BR, Xie H, Griffin T, Ondrey F. TNF-alpha drives matrix metalloproteinase-9 in squamous oral carcinogenesis. Laryngoscope. 2008: 118:1395-9. DOI: 10.1097/MLG.0b013e318174e09b10.1097/MLG.0b013e318174e09b18496150
- 12. Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG et al. Evidence that TNFTNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene. 2007: 26:1385-97. DOI: 10.1038/ sj.onc.120994510.1038/sj.onc.120994516953224
- 13. Sherr CJ. Cancer cell cycles. Science. 1996:274(5293):1672-7. DOI: 10.1126/science.274.5293.167210.1126/science.274.5293.16728939849
- 14. Witzel II, Koh LF and Perkins ND: Regulation of cyclin D1 gene expression. Biochem Soc Trans 2010: 38:217-22. DOI: 10.1042/BST038021710.1042/BST038021720074063
- 15. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene. 1995:11(5):1005-11.
- 16. Soloman DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, et al. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem. 2003 :278(16): 30339-47.10.1074/jbc.M30396920012746453
- 17. Atac A, Riecke B, Assaf AT, Gröbe A, Friedrich RE, Heiland M et. al. Lack of evidence for predictive and prognostic value of cyclin D1 gene polymorphism CCND1 G870A for oral squamous cell carcinoma. Anticancer Res. 2014:34(1):235-8.
- 18. Murali A, Nalinakumari KR, Thomas S, Kannan S. Association of single nucleotide polymorphisms in cell cycle regulatory genes with oral cancer susceptibility. Br J Oral Maxillofac Surg. 2014:52(7):652-8. DOI: 10.1016/j.bjoms.2014.05.01010.1016/j.bjoms.2014.05.01024947332
- 19. Liu W, Zhu E, Wang R, Wang L, Gao L, Yang X, Liu T. Cyclin D1 gene polymorphism, A870G, is associated with an increased risk of salivary gland tumors in the Chinese population. Cancer Epidemiol. 2011:35(4):e12-7. DOI: 10.1016/j.canep.2010.11.00110.1016/j.canep.2010.11.00121185249
- 20. Tsai MH, Tsai CW, Tsou YA, Hua CH, Hsu CF, Bau DT. Significant association of cyclin D1 single nucleotide polymorphisms with oral cancer in taiwan. Anticancer Res. 2011:31(1):227-31.
- 21. Gomes CC, Drummond SN, Guimarães AL, Andrade CI, Mesquita RA, Gomez RS. P21/WAF1 and cyclin D1 variants and oral squamous cell carcinoma. J Oral Pathol Med. 2008:37(3):151-6. DOI: 10.1111/j.1600-0714.2007.00604.x10.1111/j.1600-0714.2007.00604.x18251939
- 22. Sathyan KM, Nalinakumari KR, Abraham T, Kannan S. Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility. Oral Oncol. 2006:42(6):607-13. DOI: 10.1016/j.oraloncology.2005.10.01910.1016/j.oraloncology.2005.10.01916488657
- 23. Holley SL, Matthias C, Jahnke V, Fryer AA, Strange RC, Hoban PR. Association of cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma. Oral Oncol. 2005:41(2):156-60. DOI: 10.1016/j.oraloncology.2004.08.00510.1016/j.oraloncology.2004.08.00515695117
- 24. Nishimoto IN, Pinheiro NA, Rogatto SR, Carvalho AL, Simpson AJ, Caballero OL et al. Cyclin D1 gene polymorphism as a risk factor for squamous cell carcinoma of the upper aerodigestive system in non-alcoholics. Oral Oncol. 2004:40(6):604-10. DOI: 10.1016/j. oraloncology.2003.12.009
- 25. Wong YK, Lin SC, Chang CS, Tseng YH, Liu CJ, Lin HC et al. Cyclin D1 genotype in areca-associated oral squamous cell carcinoma. J Oral Pathol Med. 2003:32(5):265-70. DOI: 10.1034/j.1600-0714.2003.00131.x10.1034/j.1600-0714.2003.00131.x12694349
- 26. Zheng Y, Shen H, Sturgis EM, Wang LE, Eicher SA, Strom SS et al. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis. 2001:22(8):1195-9. DOI: 10.1093/carcin/22.8.119510.1093/carcin/22.8.1195
- 27. Matthias C, Branigan K, Jahnke V, Leder K, Haas J, Heighway J et al. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res. 1998:4(10):2411-8.
- 28. Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends Genet. 2004:20(9):439-44. DOI: 10.1016/j.tig.2004.06.01410.1016/j.tig.2004.06.014
- 29. Stang A: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010: 25: 603-5. DOI: 10.1007/s10654-010-9491-z10.1007/s10654-010-9491-z
- 30. Wu R, Li B. A multiplicative-epistatic model for analyzing interspecific differences in outcrossing species. Biometrics. 1999:2:355-65. DOI: 10.1111/j.0006-341X.1999.00355.x10.1111/j.0006-341X.1999.00355.x
- 31. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986:7:177-88. DOI: 10.1016/0197-2456(86)90046-210.1016/0197-2456(86)90046-2
- 32. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959:4:719-48.
- 33. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997: 315:629-34. DOI: 10.1136/ bmj.315.7109.62910.1136/bmj.315.7109.62921274539310563
- 34. Wetterslev, J., Thorlund, K., Brok, J., Gluud, C. Trial sequential analysis may establish when firm evidence is reached in cumulative metaanalysis. J. Clin. Epidemiol. 2008:61: 64-75. DOI: 10.1016/j.jclinepi.2007.03.01310.1016/j.jclinepi.2007.03.01318083463
- 35. d Brok, J., Thorlund, K., Wetterslev, J., and Gluud, C. Apparently conclusive meta-analyses may be inconclusive-Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int. J. Epidemiol 2009: 38: 287-98. DOI: 10.1093/ije/dyn18810.1093/ije/dyn18818824466
- 36. Turner, R. M., Bird, S. M., and Higgins, J. P. The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PLoS ONE 2013: 8: e59202. DOI: 10.1371/journal.pone.005920210.1371/journal.pone.0059202360974523544056
- 37. Wilson S, Jones L, Couseens C, Kathi H. The links between environmental factors, genetics, and the development of Cancer. Cancer and the Environment: Gene-Enviroment Interaction. National Academies Press (US), 2002.
- 38. Morgan, David O. Principles of CDK regulation. Nature 374, no. 6518 (1995): 131-4. DOI: 10.1038/374131a010.1038/374131a07877684
- 39. Dowdy, Steven F., Philip W. Hinds, Kenway Louie, Steven I. Reed et al. Weinberg. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 1993:73(3): 499-511. DOI: 10.1016/0092-8674(93)90137-F10.1016/0092-8674(93)90137-F
- 40. Donnellan, R., and R. Chetty. Cyclin D1 and human neoplasia. Molecular Pathology 1998):51:1. DOI: 10.1136/mp.51.1.110.1136/mp.51.1.1
- 41. Schoelch ML, Regezi. Cell cycle proteins the development of oral squamous cell carcinoma. Oral Oncol 1999: 35:333-42. DOI: 10.1016/S1368-8375(98)00098-010.1016/S1368-8375(98)00098-0
- 42. Todd R, Hind PW, Munger K, Rustgi AK, Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol Med 2002:13:51-61. DOI: 10.1177/15441113020130010610.1177/154411130201300106
- 43. Sawa H, Ohshima TA, Ukita H, Murakami H, Chiba Y, Kamada H, et al. Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene. 1998:16(13):1701-12. DOI: 10.1038/ sj.onc.120169110.1038/sj.onc.1201691
- 44. Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res.1996:68:67-108. DOI: 10.1016/S0065-230X(08)60352-810.1016/S0065-230X(08)60352-8
- 45. Wang L, Wang Z, Gao X, Li X, Sun X, Liu C. Association between Cyclin D1 polymorphism and oral cancer susceptibility: a meta-analysis. Tumour Biol. 2014:35(2):1149-55. DOI: 10.1007/s13277-013-1154-810.1007/s13277-013-1154-824186074
- 46. Wang W, Zhao Y, Yang J, Lin B, Gu H, Cao X et al. Cyclin D1 polymorphism and oral cancer: a meta-analysis. Mol Biol Rep. 2013:40(1):87-95. DOI: 10.1007/ s11033-012-2025-x10.1007/s11033-012-2025-x23111452